Back to search

Article

Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Case-Control Study in St. Petersburg, Russia

2021-08-23

Abstract excerpt

<h4>Background</h4> <h4>Results: </h4> of a randomised trial showed the safety and efficacy of Gam-COVID-Vac against COVID-19. However, compared to other vaccines used across the globe, the real-world data on the effectiveness of Gam-COVID-Vac, especially against the disease caused by Delta variant of concern, was not available. We aimed to assess the effectiveness of vaccination mainly conducted with Gam-COVID-Va...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
83d7ba73-8a1b-57eb-ba75-d51bb47b1d11
DOI
10.1101/2021.08.18.21262065
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Case-Control Study in St. Petersburg, RussiaDOI 10.1101/2021.08.18.21262065
Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: test-negative case-control studySemantic proximity
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022Semantic proximity
Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity
Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, ChinaSemantic proximity
Vaccine Coverage and Effectiveness Against Laboratory-Confirmed Symptomatic and Severe COVID-19 in Indigenous People in Brazil: A Cohort StudySemantic proximity
The Effectiveness of COVID-19 Vaccination in a Regional PopulationSemantic proximity
Comparative effectiveness of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaignSemantic proximity
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United StatesSemantic proximity
Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations.Semantic proximity
Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in ScotlandSemantic proximity
The Effect of SARS-COV-2 Variant on Respiratory Features and Mortality Among Vaccinated and Non-Fully Vaccinated PatientsSemantic proximity
Symptoms and severity in vaccinated and unvaccinated patients hospitalised with SARS-CoV-2 delta (B.1.617.2) variant infectionSemantic proximity
Select a neighboring publication to make it the new centre.